Unilever PLC UL
- Market cap
- $134.2B
- P/E
- 10.5×
Follow UL
Target Price Range
Analyst price targets
Free account| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 43.45 | 45.26 | 57.14 | 57.79 | 49.62 | 56.98 | 47.79 | 51.98 | 52.32 | 61.17 |
Analyst estimates 2026–2028 Powerpack |
Low Price
|
||
| 55.15 | 67.71 | 65.39 | 73.02 | 71.95 | 69.61 | 61.22 | 63.05 | 74.18 | 73.94 |
High Price
|
|||
| 169,000 | 161,000 | 154,848 | 149,867 | 148,949 | 148,044 | 148,000 | 128,000 | 115,964 | 96,092 |
Employees
|
|||
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Revenue/Emp
|
|||
| 58,332 | 60,714 | 60,210 | 58,218 | 57,942 | 62,047 | 63,293 | 64,509 | 65,749 | 57,139 |
Revenue
|
|||
| 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Gross Margin
|
|||
| 8,265 | 9,215 | 14,624 | 9,284 | 9,134 | 10,123 | 10,891 | 10,108 | 9,597 | 9,835 |
EBT
|
|||
| 14.17% | 15.18% | 24.29% | 15.95% | 15.76% | 16.31% | 17.21% | 15.67% | 14.60% | 17.21% |
EBT Margin
|
|||
| 6,138 | 7,331 | 11,583 | 6,749 | 6,937 | 7,833 | 8,712 | 7,728 | 6,892 | 7,029 |
Net Income
|
|||
| 1,620 | 1,738 | 2,063 | 2,220 | 2,305 | 2,086 | 2,050 | 1,709 | 1,901 | 1,531 |
Depreciation
|
|||
| 23.11 | 24.38 | 25.24 | 25.03 | 24.88 | 26.85 | 27.94 | 28.85 | 29.67 | 26.16 |
Revenue/Sh
|
|||
| 2.27 | 2.75 | 4.62 | 2.71 | 2.73 | 3.09 | 3.56 | 3.14 | 2.80 | 4.90 |
Earnings/Sh
|
|||
| 3.09 | 3.31 | 3.34 | 3.90 | 4.44 | 4.08 | 3.39 | 4.56 | 4.65 | 4.33 |
Cash Flow/Sh
|
|||
| (0.82) | (0.74) | (0.71) | (0.69) | (0.46) | (0.63) | (0.76) | (0.82) | (0.94) | (0.76) |
Capex/Sh
|
|||
| 2.27 | 2.57 | 2.64 | 3.22 | 3.99 | 3.45 | 2.63 | 3.74 | 3.70 | 3.57 |
Free CF/Sh
|
|||
| 7.44 | 6.53 | 6.09 | 6.69 | 8.66 | 10.11 | 10.09 | 10.05 | 11.02 | 9.11 |
Book Value/Sh
|
|||
| 2,525 | 2,490 | 2,385 | 2,326 | 2,329 | 2,311 | 2,265 | 2,236 | 2,216 | 2,184 |
Shares
|
|||
| 20.47 | 27.70 | 13.90 | 11.48 | 13.97 | 11.69 | 9.80 | 9.21 | 10.77 | 11.03 |
PE Ratio
|
|||
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
PS Ratio
|
|||
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
PB Ratio
|
|||
| 0.00 | 0.00 | 0.27 | 0.20 | 0.18 | 0.17 | 0.15 | 0.16 | 0.14 | 0.16 |
EV/Sales
|
|||
| 0.33 | 0.34 | 1.17 | 1.11 | 0.92 | 0.83 | 0.91 | 0.96 | 0.78 | 0.95 |
EV/FCF
|
|||
| 7,798 | 8,242 | 7,975 | 9,082 | 10,347 | 9,432 | 7,672 | 10,202 | 10,301 | 9,447 |
Op' Cash Flow
|
|||
| (2,078) | (1,832) | (1,682) | (1,600) | (1,065) | (1,466) | (1,714) | (1,843) | (2,093) | (1,658) |
Capex
|
|||
| 5,720 | 6,410 | 6,294 | 7,482 | 9,282 | 7,966 | 5,958 | 8,359 | 8,208 | 7,790 |
FCF
|
|||
| (7,383) | (7,001) | (5,068) | (5,094) | (5,066) | (8,728) | (6,606) | (6,066) | (6,536) | (5,200) |
Working Cap'
|
|||
| 17,488 | 29,305 | 30,133 | 31,000 | 32,821 | 33,665 | 30,400 | — | — | — |
Total Debt
|
|||
| (4,405) | (4,620) | (4,847) | (5,703) | (7,260) | (5,408) | (6,070) | (6,375) | (8,079) | (5,727) |
Net Debt
|
|||
| 18,790 | 16,262 | 14,517 | 15,552 | 20,167 | 23,361 | 22,864 | 22,473 | 24,407 | 19,898 |
Sh' Equity
|
|||
| 9.52% | 10.48% | 16.03% | 8.82% | 8.51% | 8.62% | 9.43% | 8.59% | 7.41% | 12.91% |
ROA
|
|||
| 37.51% | 53.74% | 95.68% | 61.89% | 45.93% | 35.84% | 42.17% | 41.00% | 38.94% | 45.09% |
ROIC
|
|||
| 31.31% | 39.04% | 72.05% | 41.90% | 35.70% | 32.88% | 34.84% | 30.97% | 26.52% | 48.36% |
ROE
|
|||
Unilever PLC peers in Household & Personal Products
| Company | Market cap | P/E | Compare |
|---|---|---|---|
| CL Colgate-Palmolive Company | $68.3B | 33.9× | Compare |
| PG Procter & Gamble Company (The) | $338.8B | 21.6× | Compare |
| EL The Estee Lauder Companies Inc. | $34.6B | 185× | Compare |
| KVUE Kenvue Inc. | $33.8B | 20.5× | Compare |
| Company | Market cap | P/E | Compare |
|---|---|---|---|
| KMB Kimberly-Clark Corporation | $32.3B | 16.7× | Compare |
| CHD Church & Dwight Co., Inc. | $22.6B | 30.9× | Compare |
| CLX The Clorox Company | $10.0B | 17.4× | Compare |
| ELF e.l.f. Beauty | $5.9B | 99.5× | Compare |
Unilever PLC (UL) key facts
- Unilever PLC (UL) is a Household & Personal Products company in the Consumer Defensive sector, traded in the US as an ADR.
- Unilever PLC’s revenue for fiscal 2025 (year ended December 2025) was GBP 57.1 billion, down 13.1% from fiscal 2024.
- Net income was GBP 7.0 billion, or GBP 4.90 per share (basic), a net margin of 18.8%.
- As of September 25, 2026, UL traded at $62.54, a market capitalization of $134.2 billion.
- At that price the stock trades at 10.5× trailing-twelve-month earnings.
- Unilever PLC pays an annual dividend of $1.82 per share, a yield of 3.86%, with a payout ratio of 52.2%.
- Return on equity was 48.4% and debt-to-equity 0.00.
Unilever PLC (UL) Latest News
21 Sep
UK CMA opened Phase 1 review of McCormick & Co. and Unilever's food-business merger worth about $65 billion, assessing whether the deal reduces competition in UK food markets. The regulator set November 11, 2026 as the deadline for an initial decision; if concerns arise, a Phase 2 review or remedies could follow. The deal would combine McCormick's spices and sauces with Unilever brands Knorr, Hellmann's, French's and Frank's RedHot, with UL owning 65% and McCormick 35% of the merged group. Unilever's food business valued at nearly $45B; McCormick at about $21B. Benefits cited include greater global scale, purchasing, manufacturing and distribution efficiencies, and a larger international revenue base for McCormick; for Unilever, proceeds support its focus on beauty, personal care and home products. Risks include delays, possible asset sales, and remedies that could erode expected synergies or push back completion. Regulatory delay and potential remedies could curb the deal’s scale benefits and timing for Unilever.
17 Sep
UK regulators are investigating the proposed $45 billion merger between McCormick and Unilever PLC. Investigation of the $45B merger creates major regulatory uncertainty that could reshape Unilever's strategic path and investor outlook.
16 Sep
UK watchdog scrutinizes Unilever-McCormick deal. Regulatory scrutiny of Unilever-McCormick deal introduces uncertainty that may affect transaction outcome and near-term strategy.
25 Aug
Unilever is divesting non-core brands and narrowing its portfolio to focus resources on high-growth categories, moving away from the traditional consumer conglomerate model in pursuit of greater efficiency and shareholder returns. Unilever's portfolio simplification marks a major strategic shift that can materially alter its competitive positioning and long-term growth trajectory.
24 Aug
Unilever split releases Magnum Ice Cream to pursue independent innovation strategy and new product development. Split allows focused innovation at Magnum that may improve product line performance but leaves Unilever core operations largely unchanged.
30 Jul
Unilever advances toward staff agreement ahead of McCormick deal to support transaction execution. Staff agreement supports smoother execution of McCormick deal with moderate effects on operations and performance.
29 Jul
Unilever lifts its outlook on progress with the McCormick deal and World Cup sponsorship. McCormick deal and World Cup sponsorship advance directly support raised outlook and stronger market positioning.
Unilever PLC released its Q2 2026 earnings via conference call, covering financial results, segment performance, and forward outlook. Quarterly earnings and guidance updates typically drive material shifts in valuation and analyst models.
28 Jul
Unilever PLC posted strong volume growth in Q2 2026 earnings call, citing strategic market expansions and operational gains that support sustained performance. Strong volume growth combined with strategic initiatives signals major positive shifts in operations and investor outlook.
Unilever posts strongest sales growth in more than a decade ahead of planned spin-off of its food business. Strongest sales in decade paired with major food business spin-off marks significant strategic shift likely to alter company trajectory.
Unilever stock rises 5.8% after volume growth improves company outlook. Volume growth signals better near-term sales trends and lifts near-term market sentiment without major strategic shifts.
Unilever achieves volume growth recovery after prior stagnation, supporting sales rebound in core consumer goods markets. Volume rebound directly lifts Unilever revenue and earnings trajectory without altering long-term industry structure.
Unilever PLC released Q2 earnings call highlights covering financial results, revenue trends and strategic updates. Q2 earnings highlights deliver financial metrics that can shift short-term investor views on Unilever.
Unilever reports strong first-half growth led by Power Brands including Dove and Vaseline. Growth from core Power Brands supports better financial results and market sentiment for Unilever.
23 Jul
McCormick outlines operating structure ahead of Unilever combination. Preparation for combination with McCormick signals major strategic shift likely to alter Unilever operations and market trajectory.
McCormick seeks a London listing ahead of its deal with Unilever without intent to raise cash. McCormick's London listing pursuit ahead of the Unilever deal points to strategic positioning that may moderately influence Unilever's operations and market stance.
McCormick plans to add London listing amid Unilever food merger. Potential merger activity around Unilever food operations may moderately shift strategic focus and investor views.
16 Jul
Unilever reshapes portfolio around core brands while questions arise over whether the company is fully valued at current levels. Portfolio reshaping around core brands may moderately affect competitive positioning and valuation metrics.
1 Jul
Reports of bid interest indicate Unilever PLC (LSE:ULVR) stock may be 23% undervalued. Bid interest reports point to possible valuation shifts and takeover speculation affecting near-term stock performance.
29 Jun
McCormick stock draws attention as a possible bargain ahead of a game-changing deal involving Unilever PLC. A game-changing Unilever deal with McCormick would likely drive major shifts in operations, portfolio, and investor sentiment.
26 Jun
Unilever PLC is exploring a $4 billion bid to acquire Thorne supplements. Potential $4 billion acquisition would mark a major strategic expansion into health supplements.
European equities declined in Friday trading. Unilever weighs a potential acquisition of Thorne valued at up to $4 billion. Unilever's consideration of a $4 billion acquisition signals a major strategic move likely to alter its trajectory and investor sentiment.
17 Jun
Accenture secures AI Factory contract with Unilever and acquires two companies to expand its capabilities. Unilever AI Factory deal with Accenture enables moderate operational efficiency gains and tech upgrades.
16 Jun
Unilever expands digital twin technology across its global manufacturing network in partnership with Accenture. Digital twin scaling supports manufacturing efficiency gains at Unilever.
13 Jun
Unilever food deal reshapes sector valuations and draws Toms Capital to McCormick. Unilever food deal alters valuations and competitive flows without directly transforming UL operations.
Ben & Jerry's push for greater autonomy tests Unilever PLC's brand governance structures and decision-making control. Brand autonomy challenges at Ben & Jerry's may moderately influence Unilever's internal governance and operational consistency.
12 Jun
Ben & Jerry's founder pushes to spin off $1 billion brand from Magnum under Unilever ownership. Brand separation effort may affect Unilever ice cream portfolio strategy without altering core operations.
11 Jun
Unilever faces an escalating legal dispute tied to its Ben & Jerry's brand, valued at $1.3 billion, with no resolution in sight. Ben & Jerry's brand fight creates moderate risk to subsidiary operations and short-term market sentiment at Unilever.
10 Jun
Nestlé's new CEO is turning the food giant around by finding its sweet spot. Nestlé turnaround strengthens a key rival and pressures Unilever's competitive position in consumer staples.
9 Jun
Unilever opens a new Connecticut beauty research hub to advance AI and quantum computing R&D. New AI and quantum R&D hub supports beauty product innovation with moderate long-term upside for Unilever.